Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RML Specialty Hospital is a not-for-profit long-term acute care hospital provider in Illinois focused on adults with prolonged, severe, and medically complex illness who still require hospital-level treatment after ICU or acute-care hospitalization. The organization operates LTCH campuses in Chicago and Hinsdale and emphasizes 24/7 on-site physician coverage, multidisciplinary care, ventilator weaning, wound care, respiratory therapy, rehabilitation, and coordinated discharge planning. RML is affiliated with Loyola Medicine and describes itself as part of a nonprofit hospital partnership with Loyola Medicine; its careers materials also note partnerships with Loyola University Health System and Advocate Health Care. Founded in 1987, RML is positioned as a nationally recognized LTCH and one of the largest ventilator-weaning hospitals in the United States. It is a healthcare services provider rather than a drug-development biotech or pharma company, so it does not have a traditional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RML Specialty Hospital.